These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1155 related articles for article (PubMed ID: 21852800)

  • 21. Oxytocin and vasopressin in the hippocampus.
    Zagrean AM; Georgescu IA; Iesanu MI; Ionescu RB; Haret RM; Panaitescu AM; Zagrean L
    Vitam Horm; 2022; 118():83-127. PubMed ID: 35180939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxytocin in the socioemotional brain: implications for psychiatric disorders.
    Kirsch P
    Dialogues Clin Neurosci; 2015 Dec; 17(4):463-76. PubMed ID: 26869847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Social preference and maternal defeat-induced social avoidance in virgin female rats: sex differences in involvement of brain oxytocin and vasopressin.
    Lukas M; Neumann ID
    J Neurosci Methods; 2014 Aug; 234():101-7. PubMed ID: 24709115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationships among estrogen receptor, oxytocin and vasopressin gene expression and social interaction in male mice.
    Murakami G; Hunter RG; Fontaine C; Ribeiro A; Pfaff D
    Eur J Neurosci; 2011 Aug; 34(3):469-77. PubMed ID: 21749489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electro-acupuncture improves the social interaction behavior of rats.
    Zhang HF; Li HX; Dai YC; Xu XJ; Han SP; Zhang R; Han JS
    Physiol Behav; 2015 Nov; 151():485-93. PubMed ID: 26265492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropeptides vasopressin (AVP), oxytocin (OXT) and corticotropin-releasing hormone (CRH) in the human hypothalamus: activity changes in aging, Alzheimer's disease and depression.
    Lucassen PJ; Tilders FJ; Salehi A; Swaab DF
    Aging (Milano); 1997; 9(4 Suppl):48-50. PubMed ID: 9358882
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative and Evolutionary Physiology of Vasopressin/ Oxytocin-Type Neuropeptide Signaling in Invertebrates.
    Odekunle EA; Elphick MR
    Front Endocrinol (Lausanne); 2020; 11():225. PubMed ID: 32362874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specification of oxytocinergic and vasopressinergic circuits in the developing mouse brain.
    Madrigal MP; Jurado S
    Commun Biol; 2021 May; 4(1):586. PubMed ID: 33990685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex differences in the regulation of social and anxiety-related behaviors: insights from vasopressin and oxytocin brain systems.
    Bredewold R; Veenema AH
    Curr Opin Neurobiol; 2018 Apr; 49():132-140. PubMed ID: 29518698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Life Adversity and Adult Social Behavior: Focus on Arginine Vasopressin and Oxytocin as Potential Mediators.
    Kompier NF; Keysers C; Gazzola V; Lucassen PJ; Krugers HJ
    Front Behav Neurosci; 2019; 13():143. PubMed ID: 31404254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Social circuits: peptidergic regulation of mammalian social behavior.
    Storm EE; Tecott LH
    Neuron; 2005 Aug; 47(4):483-6. PubMed ID: 16102531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders.
    Francis SM; Sagar A; Levin-Decanini T; Liu W; Carter CS; Jacob S
    Brain Res; 2014 Sep; 1580():199-218. PubMed ID: 24462936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative mapping reveals age and sex differences in vasopressin, but not oxytocin, immunoreactivity in the rat social behavior neural network.
    DiBenedictis BT; Nussbaum ER; Cheung HK; Veenema AH
    J Comp Neurol; 2017 Aug; 525(11):2549-2570. PubMed ID: 28340511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linking oxytocin and arginine vasopressin signaling abnormalities to social behavior impairments in Prader-Willi syndrome.
    Oztan O; Zyga O; Stafford DEJ; Parker KJ
    Neurosci Biobehav Rev; 2022 Nov; 142():104870. PubMed ID: 36113782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropeptides and the social brain: potential rodent models of autism.
    Lim MM; Bielsky IF; Young LJ
    Int J Dev Neurosci; 2005; 23(2-3):235-43. PubMed ID: 15749248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma Oxytocin and Arginine-Vasopressin Levels in Children with Autism Spectrum Disorder in China: Associations with Symptoms.
    Zhang HF; Dai YC; Wu J; Jia MX; Zhang JS; Shou XJ; Han SP; Zhang R; Han JS
    Neurosci Bull; 2016 Oct; 32(5):423-32. PubMed ID: 27342432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma oxytocin and vasopressin do not predict neuropeptide concentrations in human cerebrospinal fluid.
    Kagerbauer SM; Martin J; Schuster T; Blobner M; Kochs EF; Landgraf R
    J Neuroendocrinol; 2013 Jul; 25(7):668-73. PubMed ID: 23574490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiology of invertebrate oxytocin and vasopressin neuropeptides.
    Gruber CW
    Exp Physiol; 2014 Jan; 99(1):55-61. PubMed ID: 23955310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neonatal CSF vasopressin concentration predicts later medical record diagnoses of autism spectrum disorder.
    Oztan O; Garner JP; Constantino JN; Parker KJ
    Proc Natl Acad Sci U S A; 2020 May; 117(19):10609-10613. PubMed ID: 32341146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteolytic conversion of arginine-vasopressin and oxytocin by brain synaptic membranes. Characterization of formed peptides and mechanisms of proteolysis.
    Burbach JP; Lebouille JL
    J Biol Chem; 1983 Feb; 258(3):1487-94. PubMed ID: 6337140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.